Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization

Hematopoietic cell transplantation (HCT) is often a last resort, but potentially curative treatment option for children suffering from hematological malignancies and a variety of non-malignant disorders, such as bone marrow failure, inborn metabolic disease or immune deficiencies. Although efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Boelens, Jaap Jan, Hosszu, Kinga K., Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472532/
https://www.ncbi.nlm.nih.gov/pubmed/32974239
http://dx.doi.org/10.3389/fped.2020.00454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472532/
https://www.ncbi.nlm.nih.gov/pubmed/32974239
http://dx.doi.org/10.3389/fped.2020.00454

Ejemplares similares